Cargando…
Intravenous thrombolysis in combination with mild hypothermia therapy in the treatment of acute cerebral infarction
OBJECTIVE: To investigate the efficacy of recombinant tissue plasminogen activator (rt-PA) intravenous thrombolysis in combination with mild hypothermia therapy in the treatment of acute cerebral infarction. METHODS: One hundred and thirty-two patients with acute cerebral infarction who were admitte...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Professional Medical Publications
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6659097/ https://www.ncbi.nlm.nih.gov/pubmed/31372161 http://dx.doi.org/10.12669/pjms.35.4.311 |
_version_ | 1783439070435737600 |
---|---|
author | Liu, Xiaoying Rao, Shengli Wang, Jiajia |
author_facet | Liu, Xiaoying Rao, Shengli Wang, Jiajia |
author_sort | Liu, Xiaoying |
collection | PubMed |
description | OBJECTIVE: To investigate the efficacy of recombinant tissue plasminogen activator (rt-PA) intravenous thrombolysis in combination with mild hypothermia therapy in the treatment of acute cerebral infarction. METHODS: One hundred and thirty-two patients with acute cerebral infarction who were admitted to our hospital were selected and grouped into a control group and an observation group, 66 each group. Patients in the control group were given conventional treatment in combination with local mild hypothermia therapy, and patients in the observation group were given rt-PA intravenous thrombolysis on the basis of conventional treatment and local mild hypothermia therapy. National institute of health stroke scale (NIHSS) score and intracranial pressure (ICP) of the two groups before and after treatment was recorded. The efficacy of the two groups was evaluated. The modified Rankin scale (MRS) score was followed up for three months. The blood samples of the patients were collected before and after thrombolysis. Superoxide dismutase (SOD) and malondialdehyde (MDA) levels in the plasma were detected. RESULTS: The NIHSS score of the two groups decreased in the 1(st), 3(rd) and 7(th) day after treatment compared to before treatment (p<0.05), but the NIHSS score of the two groups had no significant difference at different time points after treatment (p>0.05). The ICP of the two groups decreased in the 1(st), 3(rd) and 7(th) day after treatment compared to before treatment (p<0.05), and the decrease of ICP of the observation group was more significant than that of the control group at the same time point (1(st), 3(rd) and 7(th) day after treatment) (p<0.05). The clinical efficacy of the observation group was higher than that of the control group after treatment, and the difference was statistically significant (p<0.05). The MDA concentration of both groups decreased at different time points after treatment (p<0.05), but the SOD concentration increased (p<0.05). The MDA concentration of the observation group was lower than that of the control group at different time points after treatment (p<0.05), and the SOD concentration of the observation group was higher than that of the control group (p<0.05). CONCLUSION: rt-PA intravenous thrombolysis in combination with mild hypothermia therapy has significant efficacy in the treatment of acute cerebral infarction. It can effectively relieve neurological function. Its action mechanism may be realized by relieving oxidative stress response. |
format | Online Article Text |
id | pubmed-6659097 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Professional Medical Publications |
record_format | MEDLINE/PubMed |
spelling | pubmed-66590972019-08-01 Intravenous thrombolysis in combination with mild hypothermia therapy in the treatment of acute cerebral infarction Liu, Xiaoying Rao, Shengli Wang, Jiajia Pak J Med Sci Original Article OBJECTIVE: To investigate the efficacy of recombinant tissue plasminogen activator (rt-PA) intravenous thrombolysis in combination with mild hypothermia therapy in the treatment of acute cerebral infarction. METHODS: One hundred and thirty-two patients with acute cerebral infarction who were admitted to our hospital were selected and grouped into a control group and an observation group, 66 each group. Patients in the control group were given conventional treatment in combination with local mild hypothermia therapy, and patients in the observation group were given rt-PA intravenous thrombolysis on the basis of conventional treatment and local mild hypothermia therapy. National institute of health stroke scale (NIHSS) score and intracranial pressure (ICP) of the two groups before and after treatment was recorded. The efficacy of the two groups was evaluated. The modified Rankin scale (MRS) score was followed up for three months. The blood samples of the patients were collected before and after thrombolysis. Superoxide dismutase (SOD) and malondialdehyde (MDA) levels in the plasma were detected. RESULTS: The NIHSS score of the two groups decreased in the 1(st), 3(rd) and 7(th) day after treatment compared to before treatment (p<0.05), but the NIHSS score of the two groups had no significant difference at different time points after treatment (p>0.05). The ICP of the two groups decreased in the 1(st), 3(rd) and 7(th) day after treatment compared to before treatment (p<0.05), and the decrease of ICP of the observation group was more significant than that of the control group at the same time point (1(st), 3(rd) and 7(th) day after treatment) (p<0.05). The clinical efficacy of the observation group was higher than that of the control group after treatment, and the difference was statistically significant (p<0.05). The MDA concentration of both groups decreased at different time points after treatment (p<0.05), but the SOD concentration increased (p<0.05). The MDA concentration of the observation group was lower than that of the control group at different time points after treatment (p<0.05), and the SOD concentration of the observation group was higher than that of the control group (p<0.05). CONCLUSION: rt-PA intravenous thrombolysis in combination with mild hypothermia therapy has significant efficacy in the treatment of acute cerebral infarction. It can effectively relieve neurological function. Its action mechanism may be realized by relieving oxidative stress response. Professional Medical Publications 2019 /pmc/articles/PMC6659097/ /pubmed/31372161 http://dx.doi.org/10.12669/pjms.35.4.311 Text en Copyright: © Pakistan Journal of Medical Sciences http://creativecommons.org/licenses/by/3.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Article Liu, Xiaoying Rao, Shengli Wang, Jiajia Intravenous thrombolysis in combination with mild hypothermia therapy in the treatment of acute cerebral infarction |
title | Intravenous thrombolysis in combination with mild hypothermia therapy in the treatment of acute cerebral infarction |
title_full | Intravenous thrombolysis in combination with mild hypothermia therapy in the treatment of acute cerebral infarction |
title_fullStr | Intravenous thrombolysis in combination with mild hypothermia therapy in the treatment of acute cerebral infarction |
title_full_unstemmed | Intravenous thrombolysis in combination with mild hypothermia therapy in the treatment of acute cerebral infarction |
title_short | Intravenous thrombolysis in combination with mild hypothermia therapy in the treatment of acute cerebral infarction |
title_sort | intravenous thrombolysis in combination with mild hypothermia therapy in the treatment of acute cerebral infarction |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6659097/ https://www.ncbi.nlm.nih.gov/pubmed/31372161 http://dx.doi.org/10.12669/pjms.35.4.311 |
work_keys_str_mv | AT liuxiaoying intravenousthrombolysisincombinationwithmildhypothermiatherapyinthetreatmentofacutecerebralinfarction AT raoshengli intravenousthrombolysisincombinationwithmildhypothermiatherapyinthetreatmentofacutecerebralinfarction AT wangjiajia intravenousthrombolysisincombinationwithmildhypothermiatherapyinthetreatmentofacutecerebralinfarction |